There is no justification for using drugs in weaning breastfeeding beyond one month after childbirth
It is the National Agency for Medicines (MSNA), which, following a national survey reports of rare but potentially serious side effects, had wished to bring this issue at EU level. For her, as for Italy, the risk / benefit ratio of this drug is unfavorable in the judgment of lactation, medical or not. " There is no justification for use of drugs in the cessation of breastfeeding beyond one month after delivery.
http://droidartists.jimdo.com/2014/07/28/our-technologies-have-become-more-fragile/
http://androidapp-games.weebly.com/blog/aesop-face-of-adversity
http://androidstars.weebly.com/blog/july-28th-2014
Indeed, mammary gland becomes increasingly autonomous and prolactin levels returned to baseline levels, " she says in her report . Moreover, the withdrawal of the newborn is in turn gradually spacing the feedings .
USA. note that the drug is banned in this use in the United States for 20 years. Pending the final position of the European Commission, the MSNA reminds physicians to be particularly vigilant with women who have risk factors for cardiovascular, neurological and psychiatric risk.
It is the National Agency for Medicines (MSNA), which, following a national survey reports of rare but potentially serious side effects, had wished to bring this issue at EU level. For her, as for Italy, the risk / benefit ratio of this drug is unfavorable in the judgment of lactation, medical or not. " There is no justification for use of drugs in the cessation of breastfeeding beyond one month after delivery.
http://droidartists.jimdo.com/2014/07/28/our-technologies-have-become-more-fragile/
http://androidapp-games.weebly.com/blog/aesop-face-of-adversity
http://androidstars.weebly.com/blog/july-28th-2014
Indeed, mammary gland becomes increasingly autonomous and prolactin levels returned to baseline levels, " she says in her report . Moreover, the withdrawal of the newborn is in turn gradually spacing the feedings .
USA. note that the drug is banned in this use in the United States for 20 years. Pending the final position of the European Commission, the MSNA reminds physicians to be particularly vigilant with women who have risk factors for cardiovascular, neurological and psychiatric risk.
No comments:
Post a Comment